WHO Collaborating Centres in Antimicrobial Resistance, Antimicrobial Use, and Infection Prevention
Antimicrobial Resistance
- WHO CC for Research and Training in Surveillance of Communicable Diseases and Antimicrobial Resistance (Sofia, Bulgaria)
- WHO CC for Antimicrobial Resistance Surveillance and Training (Nonthaburi, Thailand)
- WHO CC for International Monitoring of Bacterial Resistance to Antimicrobial Agents (Atlanta, USA)
- WHO CC for Surveillance of Antimicrobial Resistance (Boston, USA)
Specific Organisms and Diseases
- WHO CC for Sexually Transmitted Diseases (Randwick, Australia)
- WHO CC for Diarrhoeal Diseases Research (Dhaka, Bangladesh)
- WHO CC for Reference and Research on Meningococci (Marseille Armées, France)
- WHO CC for New, Emerging and Re-emerging Infectious Diseases (Jakarta, Indonesia)
- WHO CC for Prevention and Control of Sexually Transmitted Infections (London, UK)
- WHO CC for Reference and Research on Influenza (London, UK)
- WHO CC for Surveillance of Human African Trypanosomiasis, Treatment Failure and Drug Resistance (Atlanta, USA)
- WHO CC for Surveillance, Epidemiology and Control of Salmonella and other Foodborne Diseases(Atlanta, GA)
Antimicrobial Use
- WHO CC for Drug Statistics Methodology (Oslo, Norway)
- WHO CC for Essential Drugs and Hospital Supplies (Medellin, Columbia)
- WHO CC for International Drug Monitoring (Uppsala, Sweden)
- WHO CC for Research and Reference Services for Immunological Biological Products (Tokyo, Japan)
Infection Prevention and Patient Safety
- WHO CC for Health Promotion in Hospitals & Health Care (Vienna, Austria)
- WHO CC for Infection Prevention and Control (Riyadh, Saudi Arabia)
- WHO CC for Reference & Research on Hospital Infections (London, UK)
- WHO CC on Patient Safety (Geneva, Switzerland)
- WHO CC for Patient Safety Solutions (Oakbrook, USA)
- WHO CC for Nursing Human Resources Development and Patient Safety (Miami, USA)
- WHO CC for Patient Safety, Risk Management and Health Care Technology (Plymouth Meeting, USA)